Streetbeat News

PGY

Pagaya Technologies Ltd.

https://www.pagaya.com

Industry

Software - Infrastructure

Pagaya Technologies Ltd. operates as a financial technology company in Israel, the United States, and the Cayman Islands. It develops and implements proprietary artificial intelligence technology and related software solutions to assist partners to originate loans and other assets. Its partners include high-growth financial technology companies, incumbent financial institutions, auto finance providers, and brokers. The company was founded in 2016 and is headquartered in Tel Aviv, Israel.

Open

12.32

Mkt cap

947M

Volume

1.3M

High

13.17

P/E Ratio

-6.50

52-wk high

20.51

Low

12.17

Div yield

N/A

52-wk low

8.56

Pagaya Technologies Ltd. has announced that its full-year 2023 network volume is expected to surpass the higher end of its previously forecasted range of $8 billion to $8.2 billion.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 1:29 pm

Pagaya Technologies anticipates that its preliminary 2023 network volume and adjusted ABITDA will surpass the upper limits of its forecasted ranges for the fiscal year 2023. This positive outlook suggests that the company is performing better than expected in terms of both network growth and profitability.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 1:24 pm

Pagaya Technologies has announced its intention to conduct a reverse stock split of its ordinary shares, expected to occur in Q1 2024. The proposed reverse split ratio will be in the range of 1-for-10 to 1-for-15. This corporate action is typically undertaken by companies aiming to boost their stock price by reducing the number of shares outstanding, which can also help them meet minimum share price requirements for stock exchanges.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 1:23 pm

In Thursday's pre-market session, several information technology stocks showed significant movement. Gainers included LAES, MTC, AUID, PHUN, SGN, and PGY, with increases ranging from 9.35% to 13.3%. On the losing side, ASYS saw a substantial drop of 30.2% after Q4 earnings, while CPTN, SVRE, NVNI, JG, and RBT also experienced declines between 6.59% and 21.42%.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 1:07 pm

Jefferies analyst John Hecht has initiated coverage on Pagaya Technologies (NASDAQ:PGY) with a Buy rating and set a price target of $2.5.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 11:22 am

Pagaya has announced a partnership with Exeter Finance to integrate Pagaya's AI-driven auto credit-decisioning product across Exeter's network of over 13,000 auto dealerships. This collaboration aims to support auto dealerships by enhancing credit decision-making processes.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:28 pm

Wedbush Securities analysts warn of persistent funding challenges in the loan market despite a rally in shares amid a decline in treasury yields. Upstart Holdings Inc (UPST), LendingClub Corp (LC), and Pagaya Technologies Ltd (PGY) were discussed at the Disruptive Finance Forum. Upstart retains an Underperform rating with a $10 price target due to business model and credit quality pressures. Pagaya has a Neutral rating with a $2 price target, performing better than peers. LendingClub maintains an Outperform rating with an $8 price target, favored for its credit quality and business model durability.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 6:17 pm

Pagaya Technologies shares are down due to a CFO transition. Pulse Biosciences shares are up after receiving regulatory approvals for a feasibility study and news of potential stock purchases by Executive Chairman Robert W. Duggan.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 8:01 pm

U.S. stocks traded mixed with the Dow down 0.13%, NASDAQ up 0.11%, and S&P 500 down 0.08%. Real estate shares rose by 0.5%, while energy shares fell by 1.1%. U.S. new home sales declined by 5.6%. RedHill Biopharma's shares spiked 214% due to FDA market exclusivity for Talicia. Biodexa Pharmaceuticals surged 131% after acquiring a license for tolimidone. Asset Entities gained 80% after announcing a stock repurchase program. Pagaya Technologies fell 5.5% as CFO stepped down. B. Riley Financial dropped 9% despite Friday's gains. Anavex Life Sciences fell 8% after Q4 results. Oil was down 0.5%, gold up 0.5%, and silver up 1.4%. European and Asian markets closed lower.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 7:30 pm

Anavex Life Sciences Corp. (AVXL) shares dropped by 10% after reporting a Q4 net loss of $10.1 million, or 12 cents per share, compared to a net loss of $14.3 million, or 18 cents per share, in the same period last year. Other stocks experienced significant movements in Monday's mid-day session, with notable gainers including RedHill Biopharma Ltd. (RDHL), Biodexa Pharmaceuticals Plc (BDRX), and Tharimmune, Inc. (THAR), among others. Losers included 10X Capital Venture Acquisition Corp. II (VCXA), BioNexus Gene Lab Corp. (BGLC), and HCW Biologics Inc. (HCWB). Affirm Holdings, Inc. (AFRM) saw a jump of 13.7% following positive 'buy now, pay later' predictions for Cyber Monday.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 6:41 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.